Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Sandar Aye's publication output changed over time?
ScholarIQpublication output · 2023–2026
Output declined75% over the shown period — from 4 works in 2023 to 1 in 2026.
4
3
3
1
2023202420252026
What are the most-cited papers on Sandar Aye?
ScholarIQmost cited works
Health-related quality of life in subjective cognitive decline and mild cognitive impairment: a longitudinal cohort analysis
Sandar Aye, Vincent Bouteloup, Ashley Tate, Anders Wimo, Ron Handels, Delphine Jean, Bengt Winblad, Linus Jönsson
S140755874. 202320 CitationsOPEN ACCESS
Optimising Alzheimer's Disease Diagnosis and Treatment: Assessing Cost-Utility of Integrating Blood Biomarkers in Clinical Practice for Disease-Modifying Treatment
Sandar Aye, Ron Handels, Bengt Winblad, Linus Jönsson
S4210234663. 202417 CitationsOPEN ACCESS
Point of view: Challenges in implementation of new immunotherapies for Alzheimer's disease
Sandar Aye, Gunilla Johansson, Christoph Höck, Lars Lannfelt, John R. Sims, Kaj Blennow, Kristian Steen Frederiksen, Caroline Graff, José Luís Molinuevo, Philip Scheltens, Sebastian Palmqvist, Michael Schöll, Anders Wimo, Miia Kivipelto, Ron Handels, Lutz Frölich, Norbert Žilka, Martin Tolar, Peter Johannsen, Linus Jönsson, Bengt Winblad
S4210234663. 202511 CitationsOPEN ACCESS
Effect of mortality in cost‐effectiveness modeling of disease‐modifying treatment for Alzheimer's disease
Sandar Aye, Linus Jönsson, Anders Gustavsson, Ashley Tate, Sara García‐Ptacek, Maria Eriksdotter
S2898482455. 20237 CitationsOPEN ACCESS
IPECAD Modeling Workshop 2023 Cross-Comparison Challenge on Cost-Effectiveness Models in Alzheimer’s Disease
Ron Handels, William L. Herring, F. Kamgar, Sandar Aye, Ashley Tate, Colin Green, Anders Gustavsson, Anders Wimo, Bengt Winblad, Anders Sköldunger, Lars Lau Rakêt, Chelsea Bedrejo Stellick, Eldon Spackman, Jakub Hlávka, Yifan Wei, Javier Mar, Myriam Soto‐Gordoa, Inge de Kok, Chiara C. Brück, Robert M. Anderson, Peter Pemberton‐Ross, M. Urbich, Linus Jönsson
Value in Health. 20244 CitationsOPEN ACCESS
Related on ScholarIQ
Karolinska Institutet
Institution
Health-related quality of life in subjective cognitive decline and mild cognitive impairment: a longitudinal cohort analysis
Paper
Optimising Alzheimer's Disease Diagnosis and Treatment: Assessing Cost-Utility of Integrating Blood Biomarkers in Clinical Practice for Disease-Modifying Treatment
Paper
Point of view: Challenges in implementation of new immunotherapies for Alzheimer's disease
Paper
Effect of mortality in cost‐effectiveness modeling of disease‐modifying treatment for Alzheimer's disease
Paper
IPECAD Modeling Workshop 2023 Cross-Comparison Challenge on Cost-Effectiveness Models in Alzheimer’s Disease
Paper